Desafios ao controle da qualidade de medicamentos no Brasil

Silva, Cristiane Barata; Hauser-Davis, Rachel Ann; Silva, André Luiz Oliveira da; Moreira, Josino Costa.
Cad. saúde colet., (Rio J.) ; 25(3): 362-370, 2017.
Artigo em Português | BVS Integralidade, FIOCRUZ | ID: int-5225

Documentos relacionados

  1. Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data.
  2. Drug shortages. Part 2: Trends, causes and solutions.
  3. Financing Drug Innovation in the US: Current Framework and Emerging Challenges.
  4. The impact of the legal regime of intellectual property protection in the pharmaceutical market.
  5. Within-subject pharmacokinetic variability has a strong influence on individual exposure ratios in bioequivalence studies, hence on drug formulation interchangeability.
  6. Site-Specific and Country-of-Origin Labeling for Pharmaceutical Manufacturing.
  7. Does EU and US paediatric legislation improve the authorization availability of medicines for children in other countries?
  8. The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities.
  9. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring?
  10. Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods.